Target intelligence / Profile preview

Potassium voltage-gated channel subfamily A regulatory beta subunit 1 (KCNAB1)

Target
KCNAB1
Molecular classification
Ion channel (regulatory subunit), Aldo-keto reductase (AKR family)
01

Overview

Potassium voltage-gated channel subfamily A regulatory beta subunit 1 (KCNAB1) encodes a cytoplasmic regulatory (beta-1) subunit of the shaker-like voltage-gated potassium channels. The KCNAB1 protein forms complexes with Kv1 alpha subunits and modulates the gating kinetics and inactivation, particularly contributing to fast N-type inactivation. This finely tunes potassium currents that control neuronal repolarization and repetitive firing, as well as transient and slow K+ currents in cardiac myocytes. KCNAB1 also possesses NADPH-dependent aldo-keto reductase activity, which can influence channel function. Mutations and changes in KCNAB1 activity are implicated in disorders such as epilepsy, episodic ataxia, and contribute to cardiovascular rhythm control and vascular smooth muscle biology[1][2][3].

Other names
KCNA1BhKvBeta3AKR6A3Kvb1.3hKvb3KV-BETA-1HKvBeta3HKvb3potassium channel beta 3 chainpotassium channel beta3 subunitpotassium channel shaker chain beta 1apotassium channel, voltage-gated subfamily A regulatory beta subunit 1potassium voltage-gated channel subfamily A member regulatory beta subunit 1potassium voltage-gated channel, shaker-related subfamily, beta member 1
02

Mechanism of action

Modulation of N-type (fast) inactivation of Kv channels, affecting neuronal and cardiac excitability. Drugs that modulate Kv channel availability, repolarization, or inactivation may act via complexes containing KCNAB1.

03

Biological functions

Regulation of potassium channel activityModulation of neuronal excitabilityRegulation of action potential timing in neuronsRegulation of cardiac rhythmControl of cell volumeInfluences cell proliferation and apoptosis in vascular smooth muscle
04

Disease associations

EpilepsyEpisodic ataxia (type 1)Cardiovascular disease (arrhythmia)Neurodevelopmental disorders (possible association via excitability changes)
05

Safety considerations

Potential for altered neuronal or cardiac excitability leading to seizures or arrhythmias when channel function is dysregulatedSecondary effects on hormone secretion or cell proliferation possible if channel complexes are chronically modulated
06

Interacting drugs

No clinically approved drugs directly target KCNAB1.

4 more in the full profile.

07

Biomarkers

None established for routine clinical useVariations in KCNAB1 expression or genetic sequence may be investigated as biomarkers for epilepsy susceptibility or cardiac arrhythmias

Beyond the preview

Go deeper on Potassium voltage-gated channel subfamily A regulatory beta subunit 1 (KCNAB1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Potassium voltage-gated channel subfamily A regulatory beta subunit 1 (KCNAB1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call